181 related articles for article (PubMed ID: 32871983)
1. Diagnostic value of circulating tumor DNA in molecular characterization of glioma: A meta-analysis.
Kang Y; Lin X; Kang D
Medicine (Baltimore); 2020 Aug; 99(33):e21196. PubMed ID: 32871983
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor DNA in Adults With Glioma: A Systematic Review and Meta-Analysis of Biomarker Performance.
McMahon JT; Studer M; Ulrich B; Revuelta Barbero JM; Pradilla I; Palacios-Ariza MA; Pradilla G
Neurosurgery; 2022 Aug; 91(2):231-238. PubMed ID: 35535984
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients.
Guo W; Jin L; Liang J; Lin G; Zheng J; Zhou D; Zhan S; Sun H; Jiang X
Clin Chim Acta; 2022 Sep; 534():81-92. PubMed ID: 35810802
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.
Zhao J; Huang Y; Song Y; Xie D; Hu M; Qiu H; Chu J
Eur Radiol; 2020 Aug; 30(8):4664-4674. PubMed ID: 32193643
[TBL] [Abstract][Full Text] [Related]
7. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
Fujioka Y; Hata N; Akagi Y; Kuga D; Hatae R; Sangatsuda Y; Michiwaki Y; Amemiya T; Takigawa K; Funakoshi Y; Sako A; Iwaki T; Iihara K; Mizoguchi M
J Neurooncol; 2021 Mar; 152(1):47-54. PubMed ID: 33417137
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of Immunohistochemistry in Detecting MGMT Methylation Status in Patients with Glioma.
Sahara N; Hartanto RA; Yoshuantari N; Dananjoyo K; Widodo I; Malueka RG; Dwianingsih EK
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3803-3808. PubMed ID: 34967558
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.
Tang M; Deng Z; Li B; Peng Y; Song M; Liu J
Int J Biol Markers; 2017 Oct; 32(4):e421-e427. PubMed ID: 28885658
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.
Qiu M; Wang J; Xu Y; Ding X; Li M; Jiang F; Xu L; Yin R
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):206-12. PubMed ID: 25339418
[TBL] [Abstract][Full Text] [Related]
13. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.
Hao YX; Fu Q; Guo YY; Ye M; Zhao HX; Wang Q; Peng XM; Li QW; Wang RL; Xiao WH
Onco Targets Ther; 2017; 10():945-953. PubMed ID: 28243130
[TBL] [Abstract][Full Text] [Related]
15. Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis.
Gu Y; Wan C; Qiu J; Cui Y; Jiang T; Zhuang Z
PLoS One; 2020; 15(2):e0224001. PubMed ID: 32027658
[TBL] [Abstract][Full Text] [Related]
16. Cell-free microRNAs as non-invasive biomarkers in glioma: a diagnostic meta-analysis.
Wang J; Che F; Zhang J
Int J Biol Markers; 2019 Sep; 34(3):232-242. PubMed ID: 30968749
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of circulating tumor DNA in localized non-small cell lung cancer: a systematic review and meta-analysis.
Guo RQ; Peng JZ; Sun J; Li YM
Clin Exp Med; 2023 Sep; 23(5):1621-1631. PubMed ID: 36315311
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA.
Azad TD; Jin MC; Bernhardt LJ; Bettegowda C
Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor DNA
Sun X; Li H; Sun M; Yuan Y; Sun L
Future Oncol; 2019 Oct; 15(30):3513-3525. PubMed ID: 31578881
[No Abstract] [Full Text] [Related]
20. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]